| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-15 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-11 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |